Acetylcholinesterase therapies have proven beneficial in antipsychotic therapy of schizophrenia, as well as visual hallucinations and dementia in Parkinson's and Alzheimer's disease (Singh et al., 2012; Bittner et al., 2023). Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.